Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

874
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
874
Pneumothorax-I01:26

Pneumothorax-I

1.0K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.0K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.7K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

719
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
719
Types of Toxins01:36

Types of Toxins

3.1K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

928
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
928

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding Pore Filling Processes and Adsorption/Desorption Hysteresis in Nanoporous Metal-Organic Frameworks: Insights from Grand Canonical Monte Carlo Simulations and Free Energy Calculations.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

The non-haemorrhagic vagal response to trauma: a review of hypotensive and bradycardic responses to injury in the absence of bleeding.

European journal of trauma and emergency surgery : official publication of the European Trauma Society·2024
Same author

A Proposed Systematic Approach to Safe Inter Hospital Patient Transfer in Interventional Radiology: From Referral to Repatriation.

Cardiovascular and interventional radiology·2024
Same author

Computational investigation of hysteresis and phase equilibria of n-alkanes in a metal-organic framework with both micropores and mesopores.

Communications chemistry·2023
Same author

Shock in Trauma.

Emergency medicine clinics of North America·2022
Same author

Chemical stabilization of the extracellular matrix attenuates growth of experimentally induced abdominal aorta aneurysms in a large animal model.

JVS-vascular science·2021

Related Experiment Video

Updated: Dec 26, 2025

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

9.3K

Toxic inhalational injury.

Victoria Davies1, Jake Turner2, Michael Greenway2

  • 1Medical School, Keele University, Keele, UK w4h99@students.keele.ac.uk.

BMJ Case Reports
|March 13, 2020
PubMed
Summary

This case highlights challenges in diagnosing anemia during toxic inhalational injury with carbon monoxide exposure. Hydroxocobalamin is recommended as a safe and effective cyanide antidote for prehospital care.

Keywords:
antidotescarbon monoxidecyanideshydroxocobalaminpre-hospitalsmokethiosulfates

More Related Videos

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
09:16

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury

Published on: February 26, 2017

10.1K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K

Related Experiment Videos

Last Updated: Dec 26, 2025

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

9.3K
Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
09:16

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury

Published on: February 26, 2017

10.1K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K

Area of Science:

  • Emergency Medicine
  • Toxicology
  • Critical Care

Background:

  • Toxic inhalational injuries, including smoke inhalation, carbon monoxide (CO) exposure, and cyanide poisoning, present complex diagnostic and therapeutic challenges.
  • Prehospital resuscitation and emergency department management are critical for patient outcomes.

Observation:

  • A middle-aged patient experienced toxic inhalational injury, requiring immediate medical intervention.
  • Initial anemia assessment was complicated by CO's spectrophotometric interference, necessitating further laboratory confirmation.
  • Cyanide exposure can also interfere with standard hemoglobin testing, requiring alternative analytical methods.

Findings:

  • Anemia, initially suspected to be artefactual due to CO exposure, was confirmed by laboratory testing.
  • Non-cyanide based hemoglobin analysis is crucial when cyanide poisoning is suspected.
  • Hydroxocobalamin emerged as a preferred cyanide antidote due to its favorable safety profile and lack of cardiovascular side effects.

Implications:

  • Early administration of hydroxocobalamin by prehospital teams may improve outcomes for toxic inhalational injury.
  • Standard laboratory tests may require modification or alternative methods in cases of CO and cyanide exposure.
  • Further research into prehospital antidote protocols for complex toxic inhalational injuries is warranted.